Spring Health vs Lyra Health

Side-by-side comparison of model-estimated upside.

Spring Health

-35%

est. 2Y upside i

HealthcareSeries D+

Rank

#2907

Sector

Healthtech

Est. Liquidity

~2Y

Data Quality

Data: Medium

The expected equity upside over 2 years is -35%, driven by a high entry multiple of 5.28x and competitive pressure.

Last updated: July 19, 2026

Lyra Health

-32%

est. 2Y upside i

HealthcareSeries D+

Rank

#2889

Sector

HealthTech

Est. Liquidity

~2Y

Data Quality

Data: Medium

Given the negative expected upside (-32.4%) over 2 years, this equity grant is likely to lose value.

Last updated: July 3, 2026

Upside Comparison

Expected Upside

Spring Health
-35%
Lyra Health
-32%

Disclaimer: These rankings are AI-generated estimates and do not constitute financial or career advice. Always conduct your own due diligence.